Prognostic value of the interpectoral lymph nodes in breast cancer: A 20-year survival study

Clinical and Translational Oncology

Volumn 8, Issue 2, 2006, Pages 108-118

  García Vilanova Comas, Andres ^a,b   Garcia Vilanova A ^a   Fuster Diana, E ^a   Martinez Alzamora N ^c   Fernandez Tena J M ^b   Garcia Vilanova Comas J ^b   Garcia Vilanova Comas M ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^c UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

Author keywords

Breast neoplasms; Lymph node dissection; TNM classification

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOPSY; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CLASSIFICATION; CANCER GRADING; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTERPECTORAL LYMPH NODE; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MASTECTOMY; PROGNOSIS; ANTIBODY SPECIFICITY; BREAST TUMOR; CANCER STAGING; DISSECTION; EVALUATION; GENETIC VARIABILITY; HISTOLOGY; INFANT; LIFE TABLE; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SURVIVAL; THORAX;

BECLOMETASONE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOPSY; BECLOMETHASONE; BREAST NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISSECTION; FEMALE; HUMANS; INFANT; LIFE TABLES; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; ORGAN SPECIFICITY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THORAX; VARIATION (GENETICS);

EID: 33646855111     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-006-0167-9     Document Type: Article

References (34)

1. Fisher B, Bauer M, Wickerham DL, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP Update. Cancer. 1983;52:1551-7.
2. Fentiman IS, Mansel RE. The axilla: Not a no go zone. Lancet. 1991;337:221-3.
3. Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet. 1999;354:896-900.
4. Auchincloss H. Significance of location and number of axillary metastases in carcinoma of the breast. Ann Surg. 1963;158:37-46.
5. Veronesi U, Banfi A, Salvadori B, et al. Breast conservation is the treatment of choice in small breast cancer. Eur J Cancer. 1990;26:668-770.
6. Greenall MJ. How should the axilla be treated in breast cancer. Why I favour axillary node sampling in the management of breast cancer. European J Surg Oncology. 1995;21(1):2-5.
7. Davidson T. How should the axilla be treated in breast cancer. Why I favour axillary node clearance i the management of breast cancer. European J Surg Oncology. 1995;21(1):5-7.
8. Durkin K, Haagensen CD. An improved technique for the study of lymph nodes in surgical specimens. Ann Surg. 1980;191(4):419-29.
9. Rotter. Zur Topagraphie des Mamma-carcinom. Arch fur klinische Chirurgie. 1899;58:346-56.
10. Contesso G, Rouesse J, Genin J. L'envairssement ganglionare locoregional des cancers du sein. Bulletin du Cancer. 1975;62(4):359-72.
11. Grossman. Ueber die axillaren Lymphdrusen. in Innaugural dissertation. Berlin; 1896.
12. Cody HS, Egeli RA, Urban JA. Rotter's node metastases. Therapeutic and prognostic considerations in early breast carcinoma. Ann Surg. 1984;199(3):266-70.
13. Haagensen. Lymphatics of the breast, in the lymphatics in cancer. Philadelphia: W. Saunders, Editor; 1972, p. 340-4.
14. Cáceres E, Lingan M, Delgado P. Evaluation of dissection of the axilla in modified radical mastectomy. Surg Gynecol Obstet. 1976;143(3):395-7.
15. Senofsky GM, Moffat FL, Davis K, et al. Total axillary lymphadenectomy in the management of breast cancer. Arch Surg. 1991;126(11):1336-41.
16. Bale A, Gardner B, Shende M, Fromowitz F. Can interpectoral nodes be sentinel nodes? Am J Surg. 1999;178(5):560-1.
17. Dixon JM, Dobie V, Chetty U. The importance of interpectoral nodes in breast cancer. Eur J Cancer. 1993;3:334-6.
18. Danko Velimir V, Vesna R, Dubravka M, Bozena S, Fabijan K, Stjepan J. Analisis of metastatic involvement of interpectoral (Rotter's). Lymph nodes related to tumor location, size, grade and hormone receptor status in breast cancer. Tumori. 2005;91:177-81.
19. Chandawarkar RY, Shinde SR. Interpectoral nodes in carcinoma of the breast: Requiem or resurrection. J Surg Oncol. 1996;62(3):158-61.
20. Galimberti Z. Ganglios interpectorales (de Rotter) y cáncer de mama. Revista de Senología y Patología Mamaria. 1993;6(3):115-8.
21. García-Vilanova Comas A, García Vilanova A, Fuster E, Checa F. Estudio de la afectación neoplásica de los grupos ganglionares de la cadena acromiotorácica en el carcinoma de mama. Rev de Senología y Patología Mamaria. 1989;2(1):6-11.
22. Baum. The extent and necessity of axillary dissection in breast cancer surgery. in European Society of Mastology. 4th consensus Conference. 1994. Vienna-Austria.
23. Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP. Management and survival of female breast cancer. Results of a National Survey by the American College of Surgeons. Cancer. 1980;45:2917-24.
24. Sacre RA. Clinical evaluation of axillar lymph nodes compared to surgical and pathological findings. Eur J Surg Oncol. 1986;12(2):169-75.
25. Yamasaki N, Kodama H. A role of interpectoral (Rotter's) lymph node dissection in modified radical mastectomy for breast cancer. Nippon Geka Gakkai Zasshi. 1999;(11):1427-52.
26. Schwartz GF, Giuliano AE, Veronesi U, and the Consensus Conference Committee: Proceedins of the Consensus Conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22, 2001, Philadelphia, Pennsylvania. Hum Pathol. 2002;55:579-89.
27. Schwartz GF, D'Ugo DM, Rosenberg AL. Extent of axillary dissection preceding irradiation for carcinoma of the breast. Arch Surg. 1986;121(12):1595-8.
28. Veronesi U, Cascinelli N, Greco M, et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg. 1985;202:702-7.
29. UICC. TNM classification of malignant tumours. 6th edition. 2002.
30. Grabenbauer GG. Internal mammary nodes in invasive breast carcinoma. To treat or not to treat? Strahlenther Onkol. 2004;180(11):690-4.
31. Chevinsky AH, Ferrara J, James AG, Minton JP, Young D, Farrar WB. Prospective evaluation of clinical and pathological detection of axillary metastasis in patient with carcinoma of the breast. Surg. 1990;108:612-8.
32. Jansen L, Doting MH, Rutgers EJ, de Vries J, Olmos RA, Nieweg OE. Nieweg: Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer. British Journal of Surgery. 2000;87:920-5.
33. Estourgie SH, Nieweg OE, Valdés Olmos RA, et al. Lymphatic drainage patterns from the breast. Ann Surg. 2004;239(2):232-7.
34. Komenaka IK, Bauer VP, Schnabel FR, et al. Interpectoral nodes as the initial site of recurrence in breast cancer. Arch Surg. 2004;159(2):175-8.